These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1722373)

  • 21. [The effect of hemosorption on the glycoprotein concentration of the blood serum in inflammatory diseases of the large intestine].
    Ivanov AF; Eroshkina TD; Fomin SA; Musin II; Chirkin VV
    Ter Arkh; 1995; 67(2):36-9. PubMed ID: 7536960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of alpha-1-antitrypsin and thrombocytes in the assessment of inflammatory activity in Crohn disease].
    Tromm A; Hüppe D; Straub H; Krieg M; May B
    Med Klin (Munich); 1992 Feb; 87(2):53-7. PubMed ID: 1542282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.
    Eivindson M; Grønbaek H; Flyvbjerg A; Frystyk J; Zimmermann-Nielsen E; Dahlerup JF
    Growth Horm IGF Res; 2007 Feb; 17(1):33-40. PubMed ID: 17126585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Acute-phase proteins and beta 2 microglobulin in the follow-up of Crohn disease and ulcerative colitis].
    Bollbach R; Rotthauwe HW
    Klin Padiatr; 1985; 197(2):106-10. PubMed ID: 3887012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Initial clinical experiences with a simplified analytic method for fecal alpha-1-antitrypsin].
    Fischbach W; Deubel M; Boege F; Mössner J
    Z Gastroenterol; 1991 Dec; 29(12):650-4. PubMed ID: 1771947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
    Letizia C; D'Ambrosio C; Agostini D; Corsi A; Boirivant M; Pallone F; Scavo D
    Ital J Gastroenterol; 1993 Jan; 25(1):23-5. PubMed ID: 8381313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focally enhanced gastritis in children with Crohn's disease and ulcerative colitis.
    Sharif F; McDermott M; Dillon M; Drumm B; Rowland M; Imrie C; Kelleher S; Harty S; Bourke B
    Am J Gastroenterol; 2002 Jun; 97(6):1415-20. PubMed ID: 12094859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Initial personal experiences with alpha-1-antitrypsin determination in feces].
    Schwery S; Meyenberger C; Ammann R; Wirth HP
    Schweiz Med Wochenschr; 1995 Sep; 125(38):1783-7. PubMed ID: 7481635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory assessment of disease activity in childhood Crohn's disease and ulcerative colitis.
    Macfarlane PI; Miller V; Wells F; Richards B
    J Pediatr Gastroenterol Nutr; 1986 Jan; 5(1):93-6. PubMed ID: 3944748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis.
    Zilberman L; Maharshak N; Arbel Y; Rogowski O; Rozenblat M; Shapira I; Berliner S; Arber N; Dotan I
    Digestion; 2006; 73(4):205-9. PubMed ID: 16837810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [C-reactive protein usefulness in diagnosis and survey of Crohn's disease and ulcerative colitis (author's transl)].
    André C; Descos L; André F; Vignal J; Druguet M
    Gastroenterol Clin Biol; 1979 Nov; 3(11):789-94. PubMed ID: 527789
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of serum mucoprotein with serum alpha 1 acid glycoprotein, haptoglobin, and alpha 1 antitrypsin assays in monitoring inflammatory bowel disease.
    Lubega J; Davies TJ
    Clin Chim Acta; 1990 Apr; 188(1):59-69. PubMed ID: 2347083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum lysozyme in inflammatory bowel disease.
    Dobbins JW; Binder HJ; Spiro HM; Finch SC
    Gastroenterology; 1976 Mar; 70(3):469-71. PubMed ID: 1248707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Acute phase proteins in monoclonal gammapathies].
    Dubost JJ; Ristori JM; Soubrier M; Ruivard M; Sauvezie B
    Pathol Biol (Paris); 1991 Oct; 39(8):769-73. PubMed ID: 1722302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cellular and humoral indices of disease activity in inflammatory bowel disease.
    Koldkjaer O; Klitgaard NA; Schmidt KG
    Digestion; 1978; 17(5):387-95. PubMed ID: 680416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The disease activity of ulcerative colitis and Crohn's disease.
    Talstad I; Gjone E
    Scand J Gastroenterol; 1976; 11(4):403-8. PubMed ID: 935802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some serum protein studies in Crohn's disease and ulcerative colitis.
    Sandor G; Levy E; Malafosse M; Huguet C; Huguier M; Loygue J
    Res Commun Chem Pathol Pharmacol; 1975 May; 11(1):129-45. PubMed ID: 1153856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.